1. Home
  2. CLDX vs RRR Comparison

CLDX vs RRR Comparison

Compare CLDX & RRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • RRR
  • Stock Information
  • Founded
  • CLDX 1983
  • RRR 1976
  • Country
  • CLDX United States
  • RRR United States
  • Employees
  • CLDX N/A
  • RRR N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • RRR Hotels/Resorts
  • Sector
  • CLDX Health Care
  • RRR Consumer Discretionary
  • Exchange
  • CLDX Nasdaq
  • RRR Nasdaq
  • Market Cap
  • CLDX 2.9B
  • RRR 3.2B
  • IPO Year
  • CLDX 2008
  • RRR 2016
  • Fundamental
  • Price
  • CLDX $23.55
  • RRR $50.84
  • Analyst Decision
  • CLDX Buy
  • RRR Buy
  • Analyst Count
  • CLDX 8
  • RRR 12
  • Target Price
  • CLDX $64.83
  • RRR $61.50
  • AVG Volume (30 Days)
  • CLDX 1.1M
  • RRR 754.8K
  • Earning Date
  • CLDX 11-06-2024
  • RRR 11-07-2024
  • Dividend Yield
  • CLDX N/A
  • RRR 1.97%
  • EPS Growth
  • CLDX N/A
  • RRR N/A
  • EPS
  • CLDX N/A
  • RRR 2.72
  • Revenue
  • CLDX $9,976,000.00
  • RRR $1,906,030,000.00
  • Revenue This Year
  • CLDX N/A
  • RRR $13.63
  • Revenue Next Year
  • CLDX N/A
  • RRR $2.65
  • P/E Ratio
  • CLDX N/A
  • RRR $18.72
  • Revenue Growth
  • CLDX 128.55
  • RRR 12.99
  • 52 Week Low
  • CLDX $23.49
  • RRR $43.08
  • 52 Week High
  • CLDX $53.18
  • RRR $63.29
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 29.53
  • RRR 43.38
  • Support Level
  • CLDX $25.56
  • RRR $49.84
  • Resistance Level
  • CLDX $28.15
  • RRR $52.96
  • Average True Range (ATR)
  • CLDX 1.62
  • RRR 1.72
  • MACD
  • CLDX 0.14
  • RRR -0.23
  • Stochastic Oscillator
  • CLDX 1.27
  • RRR 14.27

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

About RRR Red Rock Resorts Inc.

Red Rock Resorts Inc along with its subsidiary is a gaming, development, and management company. The company mainly develops strategically located casino and entertainment properties. It generates a majority of its revenue from Casino.

Share on Social Networks: